口服胞二磷胆碱治疗弱视的疗效观察  

Efficacy of oral citicoline for amblyopia

作　　者：何昭燕[1] 王立华[1] 甘晓玲[2] 侯宝杰[1] 柳川[1] 

机构地区：[1]中国武警总医院眼科,100039 [2]北京大学第一医院眼科中心,100034

出　　处：《中国斜视与小儿眼科杂志》2012年第2期63-64,92,共3页Chinese Journal of Strabismus & Pediatric Ophthalmology

摘　　要：目的探讨口服胞二磷胆碱在弱视治疗中的I临床效果。方法选择80例（80只眼）3～9岁的弱视患者，随机分为观察组和对照组各40例（40只眼）。观察组在传统治疗的基础上口服胞二磷胆碱，对照组为单纯传统治疗。比较两组患者治疗3个月后的视力变化情况。结果观察组总有效率70．0％，对照组总有效率42．5％，两组差异有统计学意义（P=0．003）。未见明显并发症。结论口服胞二磷胆碱在弱视治疗中有效、安全。Objective To investigate the clinical efficacy of oral citicoline on the treatment of amblyopia. Methods About 80 monocular outpatients （80 eyes） with 3 to 9 years old,and they were randomly divided into ob- servation group and control group, 40 cases（40 eyes） in each group. Patients in observation group were taken oral of citicoline on the basis of the glasses, occlusion therapy for near vision; Patients in control group were only taken glasses, occlusion therapy for near vision. All patients we~ followed up for 3 months. Change of visual acuity was observed. Results The total effective rate of the observation group was 70%, and the control group was 42.5%. There wasa statistical difference between the two groups （P=0.003）. Conclusions Oral citicoline is safe and effective on the treatment of amblyopia.

关 键 词：弱视 胞二磷胆碱 

分 类 号：R777.44[医药卫生—眼科]